Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009)

Dr Reddys Laboratories (RDY) posted quarterly Asset Utilization Ratio of 0.98 for Q4 2009, up 9.52% on a QoQ basis from 0.89 in Q3 2009.

Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Asset Utilization Ratio for 1 consecutive years, with 0.98 the latest figure, recorded in Q4 2009.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.98 in Q4 2009, while the trailing twelve-month figure through Dec 2009 was 0.98 (changed N/A YoY) and the FY2026 annual result came in at 0.6, down 18.05% from the prior year.
Asset Utilization Ratio grew to 0.98 in Q4 2009 per RDY's latest filing, from 0.89 in the prior quarter.
Over the last five years, Asset Utilization Ratio for RDY reached as high as 0.98 in Q4 2009 and fell as low as 0.89 in Q3 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	0.43
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	0.62
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	0.46
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	0.43
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	0.39
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	0.65
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	0.37
10	Dr Reddys Laboratories	9.82 Bn	9.66 Bn	-	-

Download Data

Date	Value
Dec 31, 2009	0.98
Sep 30, 2009	0.89